chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vertigo after both 2nd vaccination and booster vaccination-- both 2-3 days after vaccine, woke up early morning with extreme dizziness, unable to get out of bed, entire room spinning, whenever tried to sit up.  Lasted for 3 hrs, improved after laying flat, drinking fluids.
GBS, h/a, dizziness, blurred vision, paresthesia of toes beginning 7MAY98 & progressing to slurred speech, lower extremity weakness & incontinence by 18MAY98;tx by plasmapheresis;PT ongoing;recovery complete;
High fever, bad chills/shakes, tired, sore muscles, headache, teeth throbbing
16Apr90 pt vax booster dose;  devel lethargy, temp 102F, joint aches in hands, & erythemous rash involving arms & trunk.  Seen by MD on 16Apr, 20Jun, & 13Jul, 1990 & seen by infect disease & rheumatology MD.   See worm...
Dizzy, nausea with standing, fever hard to move left shoulder. Both immunizations given in left arm 5/15/12. Sx started 5/15/12 evening and progressed in to today.
Dizziness; This is a spontaneous report from a non-contactable consumer (patient). An elderly male of an unspecified age received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) on 27Feb2021, at single dose, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. The patient had not experienced Covid-19 prior vaccination. On an unspecified date, the patient experienced dizziness. No treatment received. Post the vaccination, the patient has not been tested for COVID-19. Clinical outcome of the adverse events was unknown at time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient stated in evaluation form that she had passed out once before after giving blood for labwork. She and her mother decided to continue with the vaccination as it had never occurred before after getting a vaccine.  A few minutes after the vaccine the patient lost consciousness.  Mom stated that her face tensed up right before hand.  The patient remained in her chair for the duration of the event.  She regained consciousness about 30 to 60 seconds later, and within a few minutes she was conscious but still very shaky, pale, and hot.  She was able to sip some water and we put a cool, wet  paper towel on the back of her neck.  The patient and her mother remained seated and under observation for an additional 15 to 20 minutes with no further issues, at which point they left the store.  I followed up with the patients mother the next day and she said her daughter was exhausted last night, but this morning she woke up feeling well and went to school like normal.
First dose: She felt tired; This is a spontaneous report from a contactable consumer (patient).   A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single for covid-19 immunisation. The patient's medical history included cancer survivor and very bad digestive issues. Concomitant medications were not reported. On an unspecified date, after the first dose of the covid vaccine, she felt tired. She got the first dose of the covid vaccine, she thought that it was a low dose. She was going to feel out the first dose of the covid vaccine. But nothing really traumatic. It was not so bad. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient was brought in by his father for Tdap and varicella vaccines. No history of adverse reations to other vaccines. Feeling well today.Tdap administered IM in Left deltoid. Varicella administered in Left upper arm, SQ. Review of VIS and paper work completed. Client was feeing fine. Discussed future vaccines recommended. It was decided to administer Meningococcal now. Menactra was administered IM in Right deltod. Papaer work was updated to reflect Menactra. Family left office probably five minutes after last vaccine. Fifteen  minutes had elasped since the first  vaccines were administered. Client walked 15-20 yards and "passed out" in the elevator, falling againt the wall, possibly hitting his head and fell to the floor.  His father sought help from the staff down stairs. No seizure-like activity was noted.He was able to tell the first responders  his name and what had happened. He was sitting cross legged  with his head down, pale, and diaphoretic when I arrived with the "EPI bag." He had felt sick to his stomach and just passed out. Breathing was shallow and non labored. He was alert but weak, cool and moist to the touch . He was assisted to recline on his back, and his legs were elevated and a cool compress applied to  his forehead. Color returned to his lips in about five minutes. He was able to move all extremities. No lumps, bumps nor blood on head . No headache. B/P 110/60. Pulse 80. He sat, ate a granola bar, and felt well enough to walk. He had not had lunch and it was 2:30 PM. He left with fluids and snacks and instructions to lie down for future immunizations and blood draws.
At three weeks in from receiving the first shot I started experiences serious dizziness while looking up and leaning over.  I almost fell over several time in the next several days. The symptoms backed off that week but I have continued to get dizzy when laying down and getting up and it still is happening daily.  Due to some of the unknown potential neurological side effects of the mRNA vaccines that have not been thoroughly tested I felt it prudent to report these issues.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 03-JUN-2013, the patient was vaccinated with a dose of RECOMBIVAX HB, (lot # H015537, expiry date JUL-2015), with the same lot of improperly stored RECOMBIVAX HB. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other manufacturer (pfizer) concerned a 32 year old female. Initial information was processed along with additional information on 23-DEC-2022.  The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was not pregnant at the time of vaccination. The patient previously received two doses of pfizer biontech covid-19 vaccine (tozinameran) (Dose number in series 1) (form of admin and route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, administered first dose on 01-DEC-2020 and second dose on 01-JUL-2021 for covid-19 prophylaxis.  It was unknown whether the patient experienced any adverse events following vaccination with pfizer biontech covid-19 vaccine (tozinameran) (Dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on 01-MAY-2022 for covid-19 prophylaxis which was associated with revaccination with different covid-19 vaccine. The batch number was not reported and has been requested. Age at time of vaccination 32 years old. Concomitant medications included pseudoephedrine (from 04-DEC-2022 to 16-DEC-2022) and dayquil (from 03-dec-2022 to 10-dec-2022) for drug used for unknown indication. On 01-DEC-2022, Laboratory data included: COVID-19 virus test negative. On 02-DEC-2022, the patient had covid-19 infection and at 02-DEC-2022 to 12-DEC-2022 (DEC-2022), the patient had covid-19 virus test positive (confirmed covid-19 infection) which resulted to confirmed clinical vaccination failure (Dose number in series 2). The patient took non company co-suspect drug paxlovid (form of admin and route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, administered from 05-DEC-2022 to 09-DEC-2022 for the treatment for covid-19. On 10-DEC-2022, the symptoms were resolved. On 14-DEC-2022, the patient cough and congestion was come back and COVID-19 virus test was negative. On 16-DEC-2022, Laboratory data included: COVID-19 virus test positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable and with paxlovid was drug withdrawn. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure and revaccination with different covid-19 vaccine was not reported. This report was serious (Other Medically Important Condition). This case was associated with product quality complaint; Sender's Comments: V0: 20221251450-confirmed clinical vaccination failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
Day 1-3 sore arm  Day 8- woke up Dizzy and had dizzy spells on and off throughout the day. Around 430 pm I ended up fainting in my kitchen. I continued to have dizzy spells and feel like I had high blood pressure for another 2 weeks. After that I made an appointment with my doctor.  After multiple tests I was found to have developed impaired left ventricular relaxation, and 2nd degree heart block, resulting in a diagnosis of heart failure. I'm still waiting to see a cardiologist.
NEXT DAY - DIZZY, NAUSEOUS AND SWEATY. BLACKED OUT - LAST A COUPLE OF HOURS. DAY 3 - INJECTION SITE RED AND SWOLLEN
11:00PM 3/5/21, all day 3/6/21, slight headache 3/7/21 morning Sever Chills 11:00 PM 3/5/21 til 1:00 AM, then fever till 5:00 AM Nausea 3/6 AM Body aches 11:00PM 3/5 - all day 3/6 Fatigue all day 3/6   (Blood type A+ in case you're wanting this info too) Foggy thinking, all day 3/6 Tylenol every 4-6 hours.
Soreness at injection site. Swelling at injection site. Pain on lifting shoulder, seating or sleeping.
Developed pain in muscle (Rt deltoid) which persisted and progressed into exquisite shooting pain of the right deltoid. Unable to do any lifting and interfering with ability to do her work.
Day after shot red place size of 50 cent piece, 1 red open dot (size of dime next to it) 3rd day second red spot/lots of itching and pain. it daily got better after 1 week. Slight place left of site.
Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025620A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Jan-2021 at 3:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, ARTHRALGIA (Joint pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were drugs used for bipolar, blood pressure, heart stiffness and heart disease. Treatment for the event was not provided.  Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
On 12/2/00, this pt developed right parascapular pain and on 12/6/00 developed right hand weakness and dyscoordination. He has specific weakness of thumb and abduction of fingers with decreased pinch and grip strength. A c-spine MR was performed and did not explain symptoms. A MRI of his brain is pending. A tentative diagnosis has been made of brachial plexitis. F/U rec'd fromreporter 6/27/01 via telephone. the reporte ? that she rec'd f/u info consisting of the following. the pt has not fully recovered and has regained 70% of his strength in the R arm and shoulder and still experiences pain in the R arm  requiring daily use of motrin. The pt is seeing a neurologist. No other info was available, further inof requested from the reporter.
This spontaneous report has been received from a physician via a company representative referring to a 14 year old male patient.  The patient had no concomitant medications, no pertinent medical history and no drug reactions/allergies.  On 07-AUG-2017, the patient was vaccinated with his first dose of GARDASIL 9, 0.5 ml, intramuscular for prevention of Human Papilloma Virus (HPV) (lot# and expiration date were not reported). On the same day, 5 minutes after receiving the immunization, the patient "had tunnel vision and passed out ". The physician did check the patient's blood pressure and blood sugars and "they were normal", the patient's blood pressure was 107/70. No treatment was given for the events. At the time of the report, the outcome of events was recovered. Upon internal review, tunnel vision was determined to be medically significant.
Initial report was received from a healthcare professional on 19 September 2013. A 50-year-old female patient had received a dose two intramuscular injection in the right deltoid of FLUZONE, lot number UH899AC, on 09 September 2013. On her way home the same day, the patient reported feeling "funny". She developed a mild cough, runny nose and red itchy eyes. The cough progressed over the next five hours and she was evaluated by a physician. The patient had a heart rate of 109 and was treated with intravenous BENADRYL 50mg and TAGAMET 800mg. The diagnosis was "anaphylactic reaction to serum". The patient was re-evaluated on 10 September 2013 and condition was improved, the symptoms had resolved. The patient had an allergy to latex and a history of plantar fasciitis. At the time of the vaccination, the patient was being evaluated for chest discomfort to rule out (r/o) pleurisy. The patient had a previous dose of influenza vaccine in 2012. Outcome was recovered. Documents held by sender: None.
Pt recv vax on 1/20/98; 30 min post vax pt exp fever, shaking chills, sweating, motor tremors & headache on 1/22/98; tx=Motrin;  pt imp 1/23/98
Patient had no arm pain day of and following day of vaccine. 2 days after vaccine patient noticed limited range of motion in that arm and shooting nerve pain down from the shoulder in the arm the vaccine was given in. Patient presented at the pharmacy 2 weeks post vaccine still with limited range of motion/pain.
VACCINE WAS GIVEN TOO HIGH ON DELTOID, CAUSING BRACHIAL PAIN
Initial unsolicited case received from a pharmacist on 12 Oct 2017. This case involves 67-year-old female patient who was vaccinated with dose of FLUZONE HIGH-DOSE) (Batch number, expiry date, dose, route and site of administration were not reported) on an unknown date. Patient medical history and concomitant medications were not reported. On an unknown date, after the vaccination, patient developed pain under her sternum, and went to the emergency room and during that her liver function tests were found to be elevated, and on an unknown date, she was admitted to the hospital. On an unknown date, she was discharged after 4 days. Other relevant lab tests and corrective treatment were not reported. On an unknown date, patient recovered from the event Liver function tests raised (reported as her tests returned to normal). The outcome of the event pain under her sternum was unknown. List of documents held by sender: none. Sender's Comments: This case concerns an elderly patient who received FLUZONE HIGH-DOSE and developed elevated Liver function tests which is unlisted and pain under her sternum which is listed with vaccine. Patient was hospitalized after events. Time to onset is unknown. Further information including patient's medical history, the risks factors including any underlying disease Circumstances and patient's medical condition at the time of vaccination, concomitant medications, previous vaccination and tolerance would be needed to fully assess this case. Based on available information the role of vaccine cannot be evaluated.
Vaccine give past beyond use date of product (3/17/2023@1345)  Manufacturer was called per CDC recommendation  Dose administered past the expiration/beyond-use date --  Contact the manufacturer for information on the stability of the vaccine.  Manufacturer only has 2 days of data past excursion.
12/23/2020 I had diahrrea for two hours at 5pm, abnominal pain, I went to the ER and had a consult for the 24th and see if I could get my gallbladder out for previous problems, I had chest pain, they did emergency surgery that same day and they removed my gallbladder. I have a rash on my injection site, I think it's a christmas tree rash .
I had my first Covid19 Moderna shot on 4/1/21. Second day I had a sore arm (not an unusual side effect) but throughout the weeks after I realized my legs were tingling. My legs felt swollen (when pressed on the skin, you could see white imprint as if there was excessive water). I particularly felt my knees being swollen, almost sore. Noticed that my legs felt little numb (as if they were made out of wood?). Long walks (and I walk a lot) tired my legs more easily.  Had my second Covid 19 Moderna shot on 5/6/21. Once again I had a sore arm. About 24 hours after the vaccine, both my arms and legs were tingling. Legs felt more numb. The tingling in arms went from tip of fingers to top of shoulders. The tingling in my arms went from my feet all the way up to my waist. The sensation was definitely more intense than what I experienced after the first shot. About 1 hour after the tingling started, I checked my fever and had 100.5 F. The fever lasted 6 hours along with the tingling/numbness. After 6 hours, I can only feel little bit of tingling in my legs and a "heavy" feeling in my knees.
Information has been received on 11-SEP-2018 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 17-DEC-2009, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a health care center as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 30-AUG-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster. On or about 12-SEP-2016, the patient sought subsequent care from the same physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
skin infection @ inject site of DTAP; reddened macular area w/many pustules @ site of inject lt deltoid over 2.5 x 3.0 cm area;
Site: Swelling at Injection Site-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: SWELLING AROUND THE NECK-Medium
Patient reported pain in shoulder almost immediately after injection. She stated that she felt that the injection was given to high in the deltoid, nearly in the joint. She has seen her physician multiple times, has been given a cortisone injection and is currently still in physical therapy for this. She reported this to me today, 12/1/17, as she felt we should know for educational purposes.
A small pimple and under it a large lump appeared  in the right thigh after 2 days of receiving the shot then the 2 days after that the left thigh another huge lump after taking a 45 min walk, it  turned into a large bruise and  then cramping in my biceps and calfs also. They were hot to the touch and hurt a lot. I was not sure if they were clots. I had something similar that  happened when I first took birth control pills at 24 yrs of age and had lumps on my legs if i just bumped them. I got off of those pills immediately.  However, I never banged my upper thighs at all this was what I know is from this vaccination.
Red spot at inj site 12 days ago. No swelling or discomfort (R) leg.
Syncope episode a couple minutes after vaccination administration.  Patient did fine during vaccination.  He did not seem nervous and reported no pain from the injection.  He reporting  blacking out for a few seconds then having blurring visions feeling dizzy and light headed.  Parents and I kept him sitting and gave him gaterade.   After 10 minutes he had recovered.  Talked to patient's Father afterwards.  He reported a previous more severe syncope episode where patient "fell off exam table" from a vaccination administration.   Patient no reported problems with last years flu vaccine.   I question if patient had eaten or had water that morning.  Patient father was not sure.  Possible that not eating contributed to syncope episode with this vaccine.
large area of soreness, redness, and warmth located under and anterior to the injection site (deltoid)
swelling; itching; Arm is sore; Rash; 3 in. red circle. Inside the redness there is another circle of a different color.; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH PRURITIC (itching), VACCINATION SITE PAIN (Arm is sore), INJECTION SITE RASH (Rash) and VACCINATION SITE ERYTHEMA (3 in. red circle. Inside the redness there is another circle of a different color.) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC), METHOTREXATE, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), MONTELUKAST SODIUM (SINGULAIR), POTASSIUM and PARACETAMOL (TYLENOL) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), RASH PRURITIC (itching), VACCINATION SITE PAIN (Arm is sore), INJECTION SITE RASH (Rash) and VACCINATION SITE ERYTHEMA (3 in. red circle. Inside the redness there is another circle of a different color.). The patient was treated with CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWELLING (swelling), RASH PRURITIC (itching), VACCINATION SITE PAIN (Arm is sore), INJECTION SITE RASH (Rash) and VACCINATION SITE ERYTHEMA (3 in. red circle. Inside the redness there is another circle of a different color.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Two nights ago patient  took some Benadryl when patient  went to bed. Today, patient  put some Benadryl cream, and patient  am feeling better.